- ------ \

Patient History
UHID :-
Name:- Date:-
/6f +/LJ
Phone No.:- Age/Gender:- ltl ·9Jr'1
Chief Complaints Trustee No.:-
:- - £J?J"
U>,'1p (9 v~l0)fal"bre<i.
Past History :- r< 3 ~ o r fi
•<?~,~
lb,~ (!' .c ~{ /m 2
Family History :- 2-~-1 f1l
ITTlJ o.,t!:t
\>t~~t
tl~:
) ~ -~ h zl i~ (oS:
r.~n,\.... ~·.. L <?a'ne!, .A
Medical History &
Physical Examinat
ion
Height:-
Weight:- \o,
Appearance:- 0
~ Jaundice:- fJ,;;
'~
Anaemia:- tJo
Oral Hygiene:-G,a,f
,
\_c_ar_d_io_v___a_sc_u_la_r_S
y_s_te_m_ _-..11 ~C
: -tf)
1-
P.R:- (? b J
P.P Sugar:-
B.P:- \ i-,o ) ~

Chest Examination
SP02 q7 f·
: [?/ LA£. ~IC~

\.....
A_bd_o_m_en_E_xa_m_in_
a_tio_n_:_ ____.j Lvm) (!)
1
j!~ J"l,i,,1 M Y IM I'$

,, RMO(Resident Med
ical Officer)
Name:- '1)(l ~ivJf' tJ ~'&v
Remarks:-
Signature

'S:,~ Q P.S.P., Sector-22, Rohin

®"'
i, Delhi-110086
<l> 011-66636600,
011-459~1~11
CP info@saih.in
www.sa1h.in SAIH102/letter H;--·· 1 .....
;w er ,2JJuly 2022

C
 SHREE AGGARSAIN
INTERNATIONAL HOSPIT
- - ···-
~t d Sm t ~goorso
b y
:

ln
AL Nor
tl'l•
Ex.
Wtltort So
clt
ly ( R
t g d

_ _ __ _
)

ab No.
atientName :r~ :~ :S H JAlNI\ 111111\B\II\U\lllll1 Reg. Date : 19-Jul-2023 09:05 NA
/Sex : YRS / Male Semple Collection : 19-Jul-202310:52 NA
IONo. : 230701583 Report Date : 19-Jul-2023 12:37 PM
PD No.Nlard :I Approved Date : 19-Jul-2023 01 :29 PM
: Dr.SELF Report Status : Approved

- TRANSFUSION MEDICI
NE & IMMUNO
Status
..

Result
;pr
HEMATOLOGY
Bio.RefJnterval Unit

& Reverse Grouping 0

POSITIVE

r.Anju Kacker,MD Dr.Swastika Agarwal,M.D

nior Consultant Consultant Microbiologist

.P., Sector-22, Rohini, Delhi-

-66636600,011-4591191
l
110086 DltVINrTA VERMA
CONSULTANT, TRANSFU
® E
@)saih.in www.saih.in PriD1 By: Mr. Absh
~!a~~9iilMy
SAJH102/Lette< He3!J"IC'1 •
2022
 REE AGGARSAIN
TERNATIONAL HOSPITAL
ed by: Shrtt AQ00Mln ~~J]tlfort So<:ltty (Rtgd.)

;!:~:~SH JAIJIIIHIIBIIIIIIIIIIII Reg. Date

Sample Collection
:
:
19-Jul-2023 09:05 AM
19-Jul-2023 10:52 AM
: 43 YRS / Male Report Date : 19-Jul-2023 12:43 PM
: 230701583 : 19-Jul-2023 12:43 PM
: , Approved Date
Report Status : Approved
: Dr.SELF

Status -
BIOCHEMISTRY
Result
- --------~::....~~~~~~~,:.J
Bio.Ref.Interval
..
Uni
85 70-100 ,. mg/dl
,.

tion (la acconluct with the American diabetes associadon guidelines):

. , ....

fasting plasma glucose level below 100 mg/dL is considered normal.

A fasting plasma glucose level between 100-126 mg/dL is considered as glucose intolerant or pre diabetic. A fasting and post-
·a1 blood sugar test (after consumption of 75 gm of glucose) is recommended for all such patients.
A fasting plasma glucose level of above 126 mg/dL is highly suggestive of a diabetic state. A repeat fasting test is strongly
mmended for all such patients. A fasting plasma glucose level in excess of 126 mg/dL on both the occasions is confirmatory of a
diabetic state.

Dr.Anju Kacker,MD Dr.Swastika Agarwal,M.D :1?

Senior Consultant Consultant Mlcroblologl,t

~oR. AN KUSH SINGHAL
• . •
.S.P., Sector-22, Rohini, Delhi-110086 CONs<ILTANT BIOCHEM~. ·-·
11-66636600, 011-45911911 ='=- ...
SAIH 102/let18' Healllt9tr21G0Jay 2022
nfo@saih.in www.saih.in Print By: Mr. Akash
 ;!:~:~~!sH JAIJI IIIIIIIUIHIUIEIIIIm Sample Collection Reg. Date : 19-Jul-2023 09:05 AM
: 19-Jul-202310:52 AM
Report Date : 19-Jul-202312:55 PM
: 43 YRS / Male
Approved Date : 19-Jul-2023 01 :03 PM
: 230701583
Report Status : Approved
:I
: Dr.SELF

Bio.Ref.Interval Uni

15.1
- 13.0-17.0
g/dl

8410 -- r
4000-10000
/cumm
{Total Leucocyte Count)
mic Focusing
ntial Leucocyta Count
Flcw ~try . 59 40-80 "
33 ·20-40
"
.. _., -· .. ~.
03 01-06 "
%
,05 ,_2-10
.,.., .-
,

.,t. -
'
~0-2 "
:.:00

-~- -- 4.7-6.1
1QA6/ul
nt
• Focusing %
45.3 40-50
Cell Volume
t Detection fl.
-- 85.2 83-101
.. - __
..,
28.4 27-32
pg

g/dL
...i;;.

33.3 31-34
Lakh/cumm
3.44 1.50-4.10
Count
• Focu~ ff'lc:n/h
25* 0-10

Dr.Anju Kacker,MJ) Dr.JyotJ Bala,M.D

Dr.Sw11tlka Aaarwal,M.P
Senior Consultant JR. Consultant BJochemktry
Consultant Mlcrobloloelat
.S,P., Sector-22
11.5
66
. .
'Rohini, Delhi-110086
36600, 011-45911911
@~
nf
SAIH 10211..etter H:-i:31 Qf/Uty 2022
O@saih.in www.sa1'h .in
Print By : Mr. Akash
 Reg. Date : 19-Juf-2023 09:05 AM
; ~:~:i~~sH JA1JI 1m111111111a111111 m Sample Collection : 19-Juf-202310:52 AM
8n,e : 43 YRS / Male Report Date : 19-Jut-202312:43 PM
X : 230701583 Approved Date : 19-Juf-202312:43 PM
Report Status : Approved
:/
: Dr.SELF

BIOCHEMISTRY
Uni
J
Status Result Bio.RefJnterval

5.5
,. r1 •4.~.o
.r
..
. • • .• II • • • • l

nc Inhibition .
. . patients of Diabetes melhtus •
taliOO in Interpretation
Good control
Fair control
Action suggested

mg/dl
25 10-45
- mg/dl
1.1 ,0.2-1.2
,Serum ,,,~ mg/dL
te Kinetic .. ·.,.; a.1•: 3.4-7.0
mEq/1
.138 ·.135-148

-:...::--=
... - ...;:::- -- mEq/1
--·
- - - .. I
4.8 3.5-5.3
-- gm/dl
7.4 6.4-8.3
• , Total serum
.,,__
..
4.3 3.5-5.0
gm/dl
• Serum
gm/dl
Green ·1.·5-3.6
3.1
in
- - ---· -·
---------·- 1.4
- 0.0-2.0
.I, mg/dl
11""':- -
.3.6 2.5-4.5
orous
mg/dl
Ybdate . ..... ij174 .
150-199
sterol serum
U/L
40-129
Alkaline Pho$phatase (ALP), Serum
,AMP Buffer

Dr,AJij11 Kacker,MD
Senior Con111ltaot
Dr.Swastika Aaarwal,M.D
Consultant Mlcroblolo&lst PB, ANKUStt SINGHAL
r-7
.S.P., Sect CONSULTANJBIOCHEMIS
or-ii, Rohini, Delhi-110086
SAIH102/l.etter He~\liJJl}'1f>'2l
.1n www.sa1 . n Print Dy : Mr. Akaah
 I

Reg. Date
: 19-Jul-2023 09:05 AM
Sample CoflectJon 19-Ju,..2023 10:52 AM
:
• 43 YRS / Male Report Date 19-Jut-202312:43 PM
:
: 230701583 Approved Date : 19-Jul-202312:43 PM
:I Report Status : Approved
: Dr.SELF
9.2 ~• I
8.8-10.2 mg/dl

174 150-199 mg/dl

L ,29* 35-60 mg/dl

- 119 0-130 mg /dl

terol, Direct serum
y

0-40 mg/dl
'28
' - mg /dl
·13a 0-200

Ratio
.'

4.1* 0-3.0
L Cholesterol Ratio

triglycerides.
lesterol, HDL cholesterol and
ls, com pris ing of paramet ers total cholesterol, LDL cho r known risk factors of heart
ofilc checks cholesterol leve es men tion ed below, are considered along with othe
of the lipid profile as per the
AHA guidelin
file typically includes:
ID develop a plan of treatme
nt and follow-up. A lipid pro
erol in all the lipoprotein particles.
s all of the cholest lesterol via liver.
11.9:~s:Qlo - this test measure " because it removes excess cho
rotein o -often called "good cholesterol and con trib ute to thickening of blood vessels
lesterol" as it deposits fat
i Ii t
ol D -ca lled "ba d cho
i Ii rotein cbol ster
ldierosclerosis. particles.
lycerides in all the lipoprotein
. . • - measures all the trig A)
a He11rt Assocllllion (AH
.-AelUlia/ro• The A•e ric
HDL Cholesterol (mg/dL)
otaJ Cbo&esteroi (~d L) <40 (men); <50 (women)
Poor
Best Better
Borderline high 50-59
Best
High >=(j()

ride (mg/dL) LDL Cholesterol (mg/dL) ase

Best for people with heart dise
Best <10 of hea rt disease.
Best for pie at risk
Borderline high <JOO
Near ideal
High 100-129
Borderline bi h
Ve hi 130-159
High
lli0-189

~-Anju kicker,M o
Dr.Swastika Agarwal,M,D ;~

Glor Cooaultant
Consultant Mlcroblologlit OR. ANkUSH SINGHAl
·
P,S,p S .
., ector-22 TANT BIOCHEMim@) =
011.66G3660Q ' Rohini, Delhi-1
10086 CONS(JL
--
Info@ . , 011.45911911 i;:i
SAIH102/letter Hea8fp1
1cf1.Ny 2022
sa1h.1n
www.saih.in
Print By : Mr. Akuh
 • 21803558 11 llllfflllllllllllllllll Reg. Date
Sample Collection
: 1...,.,_2023 Ot.05AM
: 1.......20231t.52Aa,
•• Mr, MUKESH JA ttf
: 43 YRS / Male
Report Date : 1.....,_20'l312-APM
Approved Date : 1~ f2 :G P M
; 230701583
Report Status : At,JIUnd
:I
: Dr.SELF
>c=l90

-.--....,.....,.·. ·:---·" -.... -·~s. ·,:--~

•__ ~-
.
.

serum
td
"'
J :...

-~
9
.. ' ...
~-t. ,--. .
•. .- ' ;..
__,, ,;.-· -:-
..
...·.•
9 - .-
·.i
•;-~ ~ :.
·-
.1 ..:-
.. --;:
,. -

Serum •. ·
••• • ": .-
-~. .... ,...
•
~ tase (ALP), S8rl;lffl
-
,·.
:-~~~:1'

-~
_ _:.T.,;:..
m . ; ··~.
'•"
'7"'J< •

-AJiJu katkt,.Mo
llior Con111ttant
.P., Sect
1
l-66636or-22, Rohinl, Delhi-
• 60o,
011.45911911
• ~sa,h.in
~fQG:1

'Nww.salh.ln
 (;GARSAIN
EE A 0.NNo,A111L-Ex. H OSP1e1ITy <RAegdL.J
aNAT1
welfare 5oc
/ /. /
r,:: 5/lfee ,._~rsain-

AM
Reg. Date : 19-Juj..2023 09:05
JA
; !: ~ :i !! s H 1
JIIIIIWIIDIIIIUlllllfl Sample Collection : 19-Jul.2023 10:52
AM
: 19-M-202312:45
Report Date PM
: 43 YRS / Male : 19-Ju'-202312:46
Approved Date PM
: 230701583 Report Status : AJJproved

:/
: Dr.SELF
J
# SJ
I

IMMUNOASSAY
Result Bio.Ref.Interval
Status

0-4.1
0.45
, p,oci,cing
d recent ejaculation
nig n pr ostat ic hy perplasia {BPH) an rea se in PS A. How8¥er,
be inc
ection, irritation, dies to produce an aw,r
sed by prostate inf own in several stu els already eleYat8d
leWls can be also increa tal examination (ORE) has been sh tial increases in patients with PSA lev free PSA. In men wiCh
positive result Digital
rec bs tan d and is ca led
uses the most su is not protein boun al ratio is less
ant, since DRE ca . A smaJI amount ses if the h e lo tot
is clinically insignific und to se rum pr oteins
e ris k of ca nc er increa
ars to be
blood is bo ased . Th PS A ap pe
Most PSA in the
und) PS A to total PSA is decre as uring the ratio of free to total wr, boCh total and
e (unbo Me 10 ng/mL Howe
cancer the ratio of fre prob ab ility of prostate cancer. betw ee n 4 and
io the greater the PSA levels
25%. The lower the rat psies in men with hours.
ing for elimi na tin g unnecessary bio slo wly to ba seline levels within 24
promis lation, re tur nin g
PSA ilcrease imme
diately after ejacu

- PfimC.-
2:1
...:t:Z:
.:..-.:
- -71
2.0-4.4
:..::; -
... ,. ..... _ f9'dl
·0.93-1.
.1,.2· -
- ~ :;
--N
- - !'-,: ;..
ulU'ml
3.4_8-
um _
ing Hormone) ;;r
' ,-,;

'IBH {Thyroid Stimulat

)
1 (Ad11lt) Raage (uJU/mL
= ic al Cffditio
0.27-4.2
~id <-0.27

:IIJP(jlZl\'foid >S.SO
-----
(28-36 Week) 0.7-27.0
¥q8io(j(j(>l?weeb) 2.3-13.2
1o <.6 lll0oth$
0. 7-4.8 .
-:-,-is lo <14 Years 0.7-4.2
<1 9~ , erior piNiCIIY Ul

RfrAnON
0.5-3.4
ntb
•od and secreccd by tho u& . . <pc.ide.
elq
sy
d aubuaira. TSH ii tbe hypolhilaro,c Ulp
0
1C4tunut,.• :
mo ne • n with two non-covalently boun T ) and FT4 (freo T4). Additionally,
' -m g hor " glycopro
1 tei
tions of PT3 (frco 3
lo allegative involving coacentra
feedback mechanism

n,~J11~ •
&t.i4i, Cu 1111kerMD wal,M.D
Dr.Swastika A1•r
taot nt M Jerc,blolo1ilt OR. ANICUStt StHG
HAl
Consulta
,. '
,S,p S
LTANT~
011 ·, ector-22 Rohini o CONSU
-6663 '
, elhi-110086
~fo@s . 66Qo, 011. 4591t911 SAJH102/L_,
r~ ~ " .» y 2022
a1h.iri r
t Ww sa.,h.in
lillllllllii W. Prina Dy : Mr. Ab
lh
 Gf>.R':JY.." .. SPITAL
Go... AL-Ex. HO
_,,
5oCiefy (Regd.)
we:tto:;re_ __
1,i
~· • ~//....a

JAIJI IUIWIIUIHIRIUIIIII
Reg. Date
: 21803558 SH : 19-Jul-2023 09:05 AM
Sample Collection
. Mr, MUKE : 19-Jul-2023 01 :46 PM
•. 43 YRS I Male Report Date
: 19-Jul-2023 03:47 PM
Approved Date
.: 230701583 : 19-Jul-2023 04:01 PM
Report Status : Approved
:/

-_----=-=-=-=-=-=-=-=-=-=-=-=-=-=-=-=,:-
: or. SELF~-------- --_-_-__
CLINICAL PATHOLOGY
Result Bio.Ref.Interval
=]
Status Uni

YELLOW

CLEAR
. , ...
5.0* 6.0-7.5
- --· -7 C .
I
• •
1.020 1.005-1.030

-·-:
,
• '
.. NIL •
•
Ernr ol pH Indicator/ Manual: Sulfosalicy
40-70
NIL •
en
Am Dye Method
~eEsterase NIL
NEGATIVE
~~Tea

oPIC EXAMINATION.
C ----:-~. ~=·. NIL
I
-·-
.0-2- JHPF
•
Cells
I
1-2 JHPf --
• lf:\ial Cells ii
L..
1
1-2
·~ti,.
NIL

rwal,M,P
Dr.Swastika A&• t,iologi&t
Con1ultant Micro

• • Akash
Prinl DY·Mr
 I
I
. ..
: I,
, I

i I
I
, I

IIII I
Reg. Date
lection
8 Bl IIIIIIIIIIIIIIIIIIIB Sample Col
. 2180355 Report Date
SH JAIN
: Mr, MUKE
Approved o.,.
Male
: 43 YRS I ,
83 Report Statu
; 2307015

: I
: or.SELF
SSAY
IMMVNQA
Result
Status
169.4*
L
n be IMcaU N o f
in s, 2 deffclenq ca
ation. Vitam
f
li e CIIIN o
a n d m yelln form m ,r iy lo h e lp .. ., _ .
nthesi s e ered p tl
fo r D N A sy t ti I uses. Th test is Otd
essential
with folate is h e r gastro,•n es na ca
tlon and ot
,long malabso11;>
~ ll fl (; J,
,
anemia •
.-galoblastic .
f vitamin p ils
s su pple mentation o
es
In : rders, Exc G 1 1 n m a ,,
. . - . . seen rative diso lm, h lf ll rl
es , M yeloprolife efar fa ni
LJver di se as
egnancy, V eg
rier p ,d li ll .
al fu l term pr min 812 c:ar
: nc y an emia, Norm ng age, Abnonnal vffa
. . 1n defic ie
psy, Advan
ci
. . . . . . . . oblastJc anemia, Iron
reated Epile
.. .. .. MegaJ creatic deficiencies, T __ - _,
pils, Pan and Folaf8 ,. , . ~...~
f b o ll V1tamln 812 -
m en t o - .- ...-
simultaneou
sm ea su re
-- :- :--=1» t,cc ' ..:.-...: =.......:. = = ~ .. ;a

· : 11;4 •" '·= ~

'i [er""- -.. -~ L..................... , ,,
m", ..... ... .,, ...

of
. .i .. .. .. la~•
L IN IC A L LV . tieats wid a ia a J dircale. o lr a a l I•
C ally in pa y
vi tam in D status, especi nt rid:cts due to llcredillr
of in D-depeode osis ofhypcrakcmia.
assessment
r' test in the cy (cg, vitam _.
a secoad-cJrde e o f vitamin D deficien tamin D). Ditrcn:atial di
ap
2 ha,,_
c:
clinicaJ evidca an ce to 1,2.S-dihydroxy
vi ud in s ag ocakifcrol D a d •
r sterols in cl
2 a l DJ)
ta in urally simila s: exogenous (dietary. 0 f llllraYiolct filltt. B o a
•
p o f & t-so luble, struct so urce e in ffuc ac eo
n for a grou the bo dy is derived from ocbolesterol, under th
2
• delipa!io m in D in 7- deby dr
D3 h m • h
vIs. Vita the skin from D,_ . , - .
produced in
DJ is 2S -Off Yillmil
:). 1 1 -, .o ur,bioJoaic activity. D
droxyladoa ol
. Additional hy illydroxy villmia D.
mila ) vi tam in
D • otli ydroxy (OH one, to yiel
d J,25-4 illpr1Mlioe
ii
in the liver
to fCIIIII 25-la adlyroid horm a
ie cf o fpm ll ia dlo
lcium -- ,c io
lld a W nt rol
e . under the
co
•.. ., .. ~ J u 111bo1ite It stimuJata ca d bormoDe. •
potent vi tamin D 1D11 and parathyroi
y " '- it D
i, the m os t
rum calcium
.
tratioa, o fse
,up CGaccn
llin

hi-11008 6
:.,_Rohlnl, Del
91 1
, vd -459 11
alh. ln
(I Www,s
 AGGARSAll'I ITAL
t1 R EE A TION A L HtlfOortSSoPciety (RtOCf.>
5 fERN Al'llt/Jrsoln No, ,.,rlh, ,. .,•E, ,. x.. , , .W_ •
&.1
~ t, y :S N "
. -r
!fl''":

IOGRAPH Y & Coton Ponr

ecfIOCARD DOPPLER RE

rs/M
Name: Mr. Mu
kesl1 Ja in Age/Sex: 43/Y
23
6/2023 /487 Date: 19/07/20
Utb No: 2214
C
Treating Dr.: TH
VHID No: 1583
umar
Dr. Manish K
Performed By:

COMMENTS:
EF=55%)
systol ic fu nction, ( 3D LV
• Good L V
function
• Nonna! diastolic nonna/ respiratory variation.
ith
• IVC is nonnal w function
RV syst ol ic
• Normal
V cl ot.
• No LA, L
fusion.
• No pericardia/ ef
RAPHY
S BY 2 D ECHOCARDIOG
N
OBSERVATIO al Norm
E
MITRAL VALV
Normal
VE
AORTIC VAL Normal
AL VE
TRICUSPID V Normal
VALVE
PULMONARY Normal
CARDIACCHAMBERS
Normal
M
PERICARDIU

TION
STUDY O F WALL MO
2D
Normal
cle
Right Ventri Normal

Left Ventricle

@~f
==~ 21.JulY 2022
a(W8r !.
He
SAJH 102/letter
elhi-110086
r- ii, Rohini, D
11
OO, 0ll-459119
in rt www.saih.in
 ARSAll\j
t,.GG ALX. HO SPITAL
._, AJION orth·E
welfort Society (Rtgd.)

.Sh'!!'..~rsot"
'"" ~/ //

S oYM-MODE
J\r10N
Ed Es
3.1
ii, '"et-er (ell') 3.4
o0t ensioll (clll)
·il\1 011" . Oil\\ension (cm) 1.0
·ct1h" ) 1.7
e,,u, r se1itt1 "' (cm 4.4 2.7
:culct ·on r
,,t11 . ne1,s1 (en,) ( ) 1.0 1.7
,,t 0 11 ,., .. n thickness• cm 55%
}'ost 1vo ion r:ractton
,,t. E'ed 28%
.et,t1·ict1 ll\ r J• g
hortenu,
)t\l\IS

STUDY
1Nu ous & PULSE WA VE DOPPLER
PEAK VEL. Maximum PG Mean PG Regurgitation
(mfsec) mmHg mmHg
N N Nil
E=0 .79
A= 0.58
4 N Nil
1.08
N N Nil
N
PIO N N Nil
N
NARY
8

LOR FLOW MAPPING

PS/ PR.
No MS/ MR, No AS/ AR, No TS/ TR, No
No intracardiac shun t.

GHT VENTRICULAR FUN CTI ON

21m m
12

10mm
Present

n,,Ansh l
Mo Dti FAc~ Kum ar Jain Dr. Ram esh Raikar -Ned i cine
Sr CQ • FSCAI MBBS (MAHC) 1 MD ardio logy
Dt nau1 tant DrN
Pt. Of C & Head DNB FESC Atte ndin g Cons ultan t
atdio logy Sr Con sulta nt

'Roh
O
11-4S9119
. 0086
ini, DeIh1-ll
11
www. s::iih ,..
® •t
·-,'i
SAJH 102/Leltet ~ r l .2/Ju~
-
2022
 GoYALMRI&n
IAGNOSTIC CENTRE
At
Shree Aggarsain International Hospital
PSP, Sec-22, Rohini, New Delhi- I I0086

MUKESH JAIN 43Y M

Patient ID 230701513
19-Jul-2023
Age/Gender -/ -
Dr.
Report Date 19/7/202311:21:00 AM

ULTRASOUND WHOLE ABDOMEN

e liver Is enlarged in size ( 159mm) & shows diffuse Increase 1n parenchymal echogenidty•
ggestlve o~ ~rade I/ H fatty liver. There is no evidence of any focal mass lesion. The intra hepatic
scular and biliary channels are nonnal. The portal vein is normal in course and caiber.

e gal bladder is partially distended and shows grossly anechoic lumen. No obvious pericholecystic
id collection is noted. Visualized part of CBO is nonnaf in caliber.

ualized head and proximal body of pancreas is normal. Rest of the pancreas is obscured by bowel
ses.
•. ,,,.--..ht kidney measures 103 x 41mm.
ht kidney is normal in shape, size and echotexture. The renal parenchymal thickness and echogenicity
nonnal. Few concretions ranging from 2-3111111 are seen. No evidence of any hydronephrosis.

left kidney measures 106 x 56 mm. . .

Left kidney is normal in shape, size and echotexture. The renal parenchymal thickness and ~ogerncity
la normal. A tiny -3 mm concretion In upper pole Is seen. No evidence of any hydronephrosis.

Spleen is normal in size. No focal is seen.

There is no lymphadenopathy or ascites.

The urinary bladder is partially distended.

Prostate is nonnal in size with a volume of 21cc.

conela• dnkaly.
.,.,_ tlooJtMnt Is not for m«Jlco-legol puf'PO".

~ ' t . __

Oft. MANISH MALIK 01\. MANU SOlANICI DR~T

Oft. AWNISH KUMAR OR SHRIJTI MfTTAL
DRMJIITWN M88S, ON8, MNAMS M88S,MO IIIMS.IIIO
MO(MAMC) MO(MAMC) (COHSUI.TANT aAOeOIOG&Sf)
MO, OMS, FRCA (Ute) (CONSULTANT AAOIOlOGlST) (COlltSUlTANT MO!OlOG&ST)
(CONSULTANT (CONSULTANT OMCNo..:IOBOI
SR CONSULTANT & HOD OMC No.: &1059 OMC No.: 103449
IW)t0l()G&Sl} RADIOLOGIST)
OMC Ho.: 03&51 OMC No.: 0Ul049 FMf No: 164403
OMC No.: 49063

• Findings should be cltnically correlated.

. I inion and not the d Iagnos1s.
This is a professiona op D . metry (DEXA). Ultrasound ~ith ColoI Doppler,
. 28 Slice CT Scan, Bone ensi1O t'age 1 or 1
,:8cilltlee Available : 3.0 Tesla GE Pioneer M~~it!I X-Ray, OPG and Mammography.